Good News


Recent Good News Stories

A human study in Nature Communications shows epoxy-oxylipins help end inflammation by limiting intermediate monocytes, pointing to new therapies.
UCL researchers find epoxy-oxylipins act as immune “brakes,” cutting harmful monocytes and speeding pain relief in humans.
Hannah Shavit-Weinerupda